We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-12.93%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$591B
AUM Growth
-$94.6B
Cap. Flow
+$3.09B
Cap. Flow %
0.52%
Top 10 Hldgs %
20.46%
Holding
2,656
New
75
Increased
1,551
Reduced
819
Closed
97

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$2.72B
2
BKNG icon
Booking.com
BKNG
+$2.61B
3
RHT
Red Hat Inc
RHT
+$1.62B
4
JPM icon
JPMorgan Chase
JPM
+$1.43B
5
STT icon
State Street
STT
+$1.29B

Sector Composition

Rank Sector Weight
1 Healthcare 18.46%
2 Technology 17.53%
3 Financials 14.18%
4 Consumer Discretionary 14.02%
5 Communication Services 9.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WWD icon
951
Woodward
WWD
$21.4B
$35.2M 0.01%
473,463
-2,297
-0.5% -$177K
SFNC icon
952
Simmons First National
SFNC
$3.45B
$35M 0.01%
1,450,744
-157,594
-10% -$4.24M
CPRT icon
953
Copart
CPRT
$26.8B
$34.9M 0.01%
2,920,840
+44,564
+2% +$550K
INGN icon
954
Inogen
INGN
$154M
$34.8M 0.01%
280,625
-73,523
-21% -$12.1M
FBMS
955
DELISTED
The First Bancshares, Inc.
FBMS
$34.8M 0.01%
1,151,480
+202,613
+21% +$7.08M
HCCI
956
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
$34.5M 0.01%
1,499,689
+411,039
+38% +$9.67M
FBNC icon
957
First Bancorp
FBNC
$2.72B
$34.5M 0.01%
1,055,643
+19,338
+2% +$722K
AMED
958
DELISTED
Amedisys
AMED
$34.5M 0.01%
294,290
+98,118
+50% +$11.6M
EIG icon
959
Employers Holdings
EIG
$864M
$34.4M 0.01%
820,014
-41,427
-5% -$1.82M
DYNC
960
DELISTED
Vistra Energy Corp.
DYNC
$34.4M 0.01%
377,400
PH icon
961
Parker-Hannifin
PH
$135B
$34.2M 0.01%
229,123
-1,414
-0.6% -$229K
AMD icon
962
Advanced Micro Devices
AMD
$789B
$34M 0.01%
1,843,755
+374,875
+26% +$8.11M
MAIN icon
963
Main Street Capital
MAIN
$5.47B
$34M 0.01%
1,005,526
+5,635
+0.6% +$210K
UVSP icon
964
Univest Financial
UVSP
$1.18B
$33.7M 0.01%
1,563,932
-305,807
-16% -$7.44M
CAE icon
965
CAE Inc. Common Shares
CAE
$8.9B
$33.2M 0.01%
1,809,561
-1,516
-0.1% -$28.8K
BC icon
966
Brunswick
BC
$5.21B
$33.2M 0.01%
715,557
-101,611
-12% -$5.43M
ROIC
967
DELISTED
Retail Opportunity Investments Corp.
ROIC
$33.2M 0.01%
2,090,126
-1,826,510
-47% -$32.1M
CE icon
968
Celanese
CE
$4.75B
$33.2M 0.01%
368,877
+142,074
+63% +$13.9M
O icon
969
Realty Income
O
$59.6B
$33.1M 0.01%
542,101
+17,629
+3% +$1.05M
GMED icon
970
Globus Medical
GMED
$11.5B
$33.1M 0.01%
764,854
+50,138
+7% +$2.5M
HI
971
DELISTED
Hillenbrand
HI
$33.1M 0.01%
872,335
+2,080
+0.2% +$95K
ADNT icon
972
Adient
ADNT
$1.44B
$33.1M 0.01%
2,196,995
-469,206
-18% -$12.1M
BEAT
973
DELISTED
BioTelemetry, Inc.
BEAT
$33M 0.01%
552,954
+46,802
+9% +$2.81M
CBIO
974
Crescent Biopharma
CBIO
$610M
$32.8M 0.01%
34,626
+190
+0.6% +$229K
CHH icon
975
Choice Hotels
CHH
$4.71B
$32.6M 0.01%
455,216
+10,165
+2% +$763K

Similar funds

T. Rowe Price Associates's Q4 2018 Portfolio in Review

As of Q4 2018, T. Rowe Price Associates held 2,656 positions worth $591B, down 14% from $685B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

T. Rowe Price Associates's Q4 2018 filing shows 75 new, 1,551 increased, 819 reduced and 97 closed positions. Its largest new stake was StoneCo: 28,883,228 shares worth $519M. The largest sale was Tesla, an estimated $2.72B.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Financials.

  • T. Rowe Price Associates's largest Q4 2018 buy was StoneCo: 28,883,228 shares worth $519M.
  • T. Rowe Price Associates added most to Meta Platforms (Facebook) in Q4 2018, an estimated $2.16B increase.
  • T. Rowe Price Associates's biggest Q4 2018 reduction was Tesla, cutting an estimated $2.72B.
  • T. Rowe Price Associates fully exited Aetna Inc in Q4 2018, selling an estimated $600M.
  • T. Rowe Price Associates's ten largest holdings make up 20% of its $591B portfolio in Q4 2018.
  • T. Rowe Price Associates opened 75 new positions and closed 97 in Q4 2018.
  • T. Rowe Price Associates's portfolio value fell 14% quarter-over-quarter to $591B.

Based on T. Rowe Price Associates's 13F filing for Q4 2018, filed 14 Feb 2019.